Syndrome d'activation macrophagique : une complication rare du syndrome inflammatoire multisystémique de l'enfant lié à la COVID-19

Auteur/ices

  • I Maaloul (1) Faculty of medicine of Sfax. Department of paediatrics. Hedi Chaker Hospital. Sfax, TUNISIA ; (2) Laboratory of Hematology. Hedi Chaker Hospital. Sfax, TUNISIA Auteur·e
  • B Elleuch (1) Faculty of medicine of Sfax. Department of paediatrics. Hedi Chaker Hospital. Sfax, TUNISIA ; (2) Laboratory of Hematology. Hedi Chaker Hospital. Sfax, TUNISIA Auteur·e
  • M Chaari (1) Faculty of medicine of Sfax. Department of paediatrics. Hedi Chaker Hospital. Sfax, TUNISIA ; (2) Laboratory of Hematology. Hedi Chaker Hospital. Sfax, TUNISIA Auteur·e
  • S Ben Ameur (1) Faculty of medicine of Sfax. Department of paediatrics. Hedi Chaker Hospital. Sfax, TUNISIA ; (2) Laboratory of Hematology. Hedi Chaker Hospital. Sfax, TUNISIA Auteur·e
  • H Aloulou (1) Faculty of medicine of Sfax. Department of paediatrics. Hedi Chaker Hospital. Sfax, TUNISIA ; (2) Laboratory of Hematology. Hedi Chaker Hospital. Sfax, TUNISIA Auteur·e
  • T Kamoun (1) Faculty of medicine of Sfax. Department of paediatrics. Hedi Chaker Hospital. Sfax, TUNISIA ; (2) Laboratory of Hematology. Hedi Chaker Hospital. Sfax, TUNISIA Auteur·e

Mots-clés :

macrophagic activation syndrome, multisystem inflammatory syndrome in children, child, Kawasaki disease, COVID19

Résumé

Macrophagic activation syndrome (MAS) also known as secondary hemophagocytic lymphohistiocytosis, is a rare and potentially fatal condition that has been described as a rare complication of multisystem inflammatory syndrome in children (MIS-C) related to COVID19. Here we report a 9-year-old-girl who presented MAS complicating MIS-C.

Téléchargements

Publiée

2022-03-31

Numéro

No 25 (2022): Janvier / Mars 2022

Rubrique

Fait clinique

Catégories